Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global CAR-T Cellular Immunotherapy Market Growth (Status and Outlook) 2021-2026

  • LP 4600095
  • 83 Pages
  • July 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of CAR-T Cellular Immunotherapy will have significant change from previous year. By the most conservative estimates of global CAR-T Cellular Immunotherapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CAR-T Cellular Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cellular Immunotherapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Allogeneic

Autologous

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Hospital

Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Fosun Kite Biotechnology

Gilead Sciences

Novartis

Bristol-Myers Squibb

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global CAR-T Cellular Immunotherapy Market Size 2016-2026

2.1.2 CAR-T Cellular Immunotherapy Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 CAR-T Cellular Immunotherapy Segment by Type

2.2.1 Allogeneic

2.2.2 Allogeneic

2.3 CAR-T Cellular Immunotherapy Market Size by Type

2.3.1 Global CAR-T Cellular Immunotherapy Market Size CAGR by Type

2.3.2 Global CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

2.4 CAR-T Cellular Immunotherapy Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 CAR-T Cellular Immunotherapy Market Size by Application

2.5.1 Global CAR-T Cellular Immunotherapy Market Size CAGR by Application

2.5.2 Global CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

3 CAR-T Cellular Immunotherapy Market Size by Players

3.1 CAR-T Cellular Immunotherapy Market Size Market Share by Players

3.1.1 Global CAR-T Cellular Immunotherapy Revenue by Players (2019-2021E)

3.1.2 Global CAR-T Cellular Immunotherapy Revenue Market Share by Players (2019-2021E)

3.2 Global CAR-T Cellular Immunotherapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 CAR-T Cellular Immunotherapy by Regions

4.1 CAR-T Cellular Immunotherapy Market Size by Regions (2016-2021)

4.2 Americas CAR-T Cellular Immunotherapy Market Size Growth (2016-2021)

4.3 APAC CAR-T Cellular Immunotherapy Market Size Growth (2016-2021)

4.4 Europe CAR-T Cellular Immunotherapy Market Size Growth (2016-2021)

4.5 Middle East & Africa CAR-T Cellular Immunotherapy Market Size Growth (2016-2021)

5 Americas

5.1 Americas CAR-T Cellular Immunotherapy Market Size by Country (2016-2021)

5.2 Americas CAR-T Cellular Immunotherapy Market Size by Type (2016-2021)

5.3 Americas CAR-T Cellular Immunotherapy Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC CAR-T Cellular Immunotherapy Market Size by Region (2016-2021)

6.2 APAC CAR-T Cellular Immunotherapy Market Size by Type (2016-2021)

6.3 APAC CAR-T Cellular Immunotherapy Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe CAR-T Cellular Immunotherapy by Country (2016-2021)

7.2 Europe CAR-T Cellular Immunotherapy Market Size by Type (2016-2021)

7.3 Europe CAR-T Cellular Immunotherapy Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa CAR-T Cellular Immunotherapy by Region (2016-2021)

8.2 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2016-2021)

8.3 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global CAR-T Cellular Immunotherapy Market Forecast

10.1 Global CAR-T Cellular Immunotherapy Forecast by Regions (2021-2026)

10.1.1 Global CAR-T Cellular Immunotherapy Forecast by Regions (2021-2026)

10.1.2 Americas CAR-T Cellular Immunotherapy Forecast

10.1.3 APAC CAR-T Cellular Immunotherapy Forecast

10.1.4 Europe CAR-T Cellular Immunotherapy Forecast

10.1.5 Middle East & Africa CAR-T Cellular Immunotherapy Forecast

10.2 Americas CAR-T Cellular Immunotherapy Forecast by Countries (2021-2026)

10.2.1 United States CAR-T Cellular Immunotherapy Market Forecast

10.2.2 Canada CAR-T Cellular Immunotherapy Market Forecast

10.2.3 Mexico CAR-T Cellular Immunotherapy Market Forecast

10.2.4 Brazil CAR-T Cellular Immunotherapy Market Forecast

10.3 APAC CAR-T Cellular Immunotherapy Forecast by Region (2021-2026)

10.3.1 China CAR-T Cellular Immunotherapy Market Forecast

10.3.2 Japan CAR-T Cellular Immunotherapy Market Forecast

10.3.3 Korea CAR-T Cellular Immunotherapy Market Forecast

10.3.4 Southeast Asia CAR-T Cellular Immunotherapy Market Forecast

10.3.5 India CAR-T Cellular Immunotherapy Market Forecast

10.3.6 Australia CAR-T Cellular Immunotherapy Market Forecast

10.4 Europe CAR-T Cellular Immunotherapy Forecast by Country (2021-2026)

10.4.1 Germany CAR-T Cellular Immunotherapy Market Forecast

10.4.2 France CAR-T Cellular Immunotherapy Market Forecast

10.4.3 UK CAR-T Cellular Immunotherapy Market Forecast

10.4.4 Italy CAR-T Cellular Immunotherapy Market Forecast

10.4.5 Russia CAR-T Cellular Immunotherapy Market Forecast

10.5 Middle East & Africa CAR-T Cellular Immunotherapy Forecast by Region (2021-2026)

10.5.1 Egypt CAR-T Cellular Immunotherapy Market Forecast

10.5.2 South Africa CAR-T Cellular Immunotherapy Market Forecast

10.5.3 Israel CAR-T Cellular Immunotherapy Market Forecast

10.5.4 Turkey CAR-T Cellular Immunotherapy Market Forecast

10.5.5 GCC Countries CAR-T Cellular Immunotherapy Market Forecast

10.6 Global CAR-T Cellular Immunotherapy Forecast by Type (2021-2026)

10.7 Global CAR-T Cellular Immunotherapy Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Fosun Kite Biotechnology

11.1.1 Fosun Kite Biotechnology Company Information

11.1.2 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Offered

11.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Fosun Kite Biotechnology Main Business Overview

11.1.5 Fosun Kite Biotechnology Latest Developments

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Information

11.2.2 Gilead Sciences CAR-T Cellular Immunotherapy Product Offered

11.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Gilead Sciences Main Business Overview

11.2.5 Gilead Sciences Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis CAR-T Cellular Immunotherapy Product Offered

11.3.3 Novartis CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Information

11.4.2 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Offered

11.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Bristol-Myers Squibb Main Business Overview

11.4.5 Bristol-Myers Squibb Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. CAR-T Cellular Immunotherapy Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Allogeneic

Table 3. Major Players of Autologous

Table 4. CAR-T Cellular Immunotherapy Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 5. Global CAR-T Cellular Immunotherapy Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

Table 7. CAR-T Cellular Immunotherapy Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global CAR-T Cellular Immunotherapy Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

Table 10. Global CAR-T Cellular Immunotherapy Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global CAR-T Cellular Immunotherapy Revenue Market Share by Players (2019-2021E)

Table 12. CAR-T Cellular Immunotherapy Key Players Head office and Products Offered

Table 13. CAR-T Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global CAR-T Cellular Immunotherapy Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global CAR-T Cellular Immunotherapy Market Size Market Share by Regions 2016-2021

Table 18. Americas CAR-T Cellular Immunotherapy Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Country (2016-2021)

Table 20. Americas CAR-T Cellular Immunotherapy Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

Table 22. Americas CAR-T Cellular Immunotherapy Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

Table 24. APAC CAR-T Cellular Immunotherapy Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Region (2016-2021)

Table 26. APAC CAR-T Cellular Immunotherapy Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

Table 28. APAC CAR-T Cellular Immunotherapy Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

Table 30. Europe CAR-T Cellular Immunotherapy Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Country (2016-2021)

Table 32. Europe CAR-T Cellular Immunotherapy Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

Table 34. Europe CAR-T Cellular Immunotherapy Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of CAR-T Cellular Immunotherapy

Table 43. Key Application and Potential Industries of CAR-T Cellular Immunotherapy

Table 44. Key Challenges of CAR-T Cellular Immunotherapy

Table 45. Key Trends of CAR-T Cellular Immunotherapy

Table 46. Global CAR-T Cellular Immunotherapy Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Regions (2021-2026)

Table 48. Global CAR-T Cellular Immunotherapy Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global CAR-T Cellular Immunotherapy Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global CAR-T Cellular Immunotherapy Market Size Market Share Forecast by Application (2021-2026)

Table 52. Fosun Kite Biotechnology Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors

Table 53. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Offered

Table 54. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Fosun Kite Biotechnology Main Business

Table 56. Fosun Kite Biotechnology Latest Developments

Table 57. Gilead Sciences Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors

Table 58. Gilead Sciences CAR-T Cellular Immunotherapy Product Offered

Table 59. Gilead Sciences Main Business

Table 60. Gilead Sciences CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Gilead Sciences Latest Developments

Table 62. Novartis Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors

Table 63. Novartis CAR-T Cellular Immunotherapy Product Offered

Table 64. Novartis Main Business

Table 65. Novartis CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Novartis Latest Developments

Table 67. Bristol-Myers Squibb Details, Company Type, CAR-T Cellular Immunotherapy Area Served and Its Competitors

Table 68. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Offered

Table 69. Bristol-Myers Squibb Main Business

Table 70. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. CAR-T Cellular Immunotherapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global CAR-T Cellular Immunotherapy Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2020

Figure 7. CAR-T Cellular Immunotherapy in Hospital

Figure 8. Global CAR-T Cellular Immunotherapy Market: Hospital (2016-2021) & ($ Millions)

Figure 9. CAR-T Cellular Immunotherapy in Pharmacy

Figure 10. Global CAR-T Cellular Immunotherapy Market: Pharmacy (2016-2021) & ($ Millions)

Figure 11. CAR-T Cellular Immunotherapy in Other

Figure 12. Global CAR-T Cellular Immunotherapy Market: Other (2016-2021) & ($ Millions)

Figure 13. Global CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2020

Figure 14. Global CAR-T Cellular Immunotherapy Revenue Market Share by Player in 2020

Figure 15. Global CAR-T Cellular Immunotherapy Market Size Market Share by Regions (2016-2021)

Figure 16. Americas CAR-T Cellular Immunotherapy Market Size 2016-2021 ($ Millions)

Figure 17. APAC CAR-T Cellular Immunotherapy Market Size 2016-2021 ($ Millions)

Figure 18. Europe CAR-T Cellular Immunotherapy Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa CAR-T Cellular Immunotherapy Market Size 2016-2021 ($ Millions)

Figure 20. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Country in 2020

Figure 21. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2020

Figure 22. Americas CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2020

Figure 23. United States CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Regions in 2020

Figure 27. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2020

Figure 28. APAC CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2020

Figure 29. China CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 33. India CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Country in 2020

Figure 36. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2020

Figure 37. Europe CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2020

Figure 38. Germany CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 39. France CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa CAR-T Cellular Immunotherapy Market Size Market Share by Application in 2020

Figure 46. Egypt CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country CAR-T Cellular Immunotherapy Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 52. APAC CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 53. Europe CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 55. United States CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 56. Canada CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 57. Mexico CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 58. Brazil CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 59. China CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 60. Japan CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 61. Korea CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 63. India CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 64. Australia CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 65. Germany CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 66. France CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 67. UK CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 68. Italy CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 69. Russia CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 70. Spain CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 71. Egypt CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 72. South Africa CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 73. Israel CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 74. Turkey CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country CAR-T Cellular Immunotherapy Market Size 2021-2026 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390